Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04612166 · ClinicalTrials.gov registry record · NA
Medication Empowerment and Deprescription for Safety (MEDS) Study
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 398
- Enrollment target
NCT04612166 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 398 participants.
The verdict
NCT04612166, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
Study Summary
The long-term goal of this pragmatic, cluster randomized study is to develop a sustainable program for healthcare systems to reduce fatal and nonfatal falls among high-risk older adults living independently in their communities. This study will examine how a medication care plan, grounded in established medication deprescribing and tapering frameworks, can be implemented in primary care clinics to reduce falls among older adults living in rural Iowa communities. The study is a collaboration between researchers and clinical pharmacists at the University of Iowa and a clinical team from the MercyOneSM Health Network, which is a non-academic healthcare system with significant reach into rural Iowa communities The study's specific goals are as followed: * Aim 1: Examine the effectiveness of a clinic-based, individualized medication care plan in reducing rates of all falls including medically treated falls (sub-aim 1a) and motor vehicle charges and crashes (sub-aim 1b) among older adults seen in rural primary care clinics. * Aim 2: Identify provider and patient factors that are associated with patient adherence to medication deprescribing and discontinuation recommendations. * Aim 3\*: Evaluate implementation of the medication care plan to understand its acceptability, usability and relevance among healthcare system administrators, clinics (clinic managers and clinical staff), providers (health coaches, pharmacists, prescribers) and participants. Note\*: Only Aims 1 and 2 (i.e., pertinent to the clinical trial) will be described in this clinicaltrials.gov study description. Intervention and control participants will participate in: * Baseline assessment * Quarterly follow-up assessments * Monthly falls tracking Additionally, intervention participants will receive: • An individualized medication action plan to deprescribe medications that put them at high risk for a fall Researchers will compare intervention and control participants for changes in self-reported fa
Interventions
- BEHAVIORAL Medication Action Plan and Patient Empowerment (MAP-PE )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04612166
The ClinicalTrials.gov registry entry for NCT04612166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 398 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medication Action Plan and Patient Empowerment (MAP-PE ) is the first listed.
NCT04612166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04612166 about?
NCT04612166 is a clinical study titled "Medication Empowerment and Deprescription for Safety (MEDS) Study". The long-term goal of this pragmatic, cluster randomized study is to develop a sustainable program for healthcare systems to reduce fatal and nonfatal falls among high-risk older adults living independently in their communities. This study will examine how a medication care plan, grounded in establi...
What is the current status of trial NCT04612166?
This trial is currently completed. It is a NA study. The enrollment target is 398 participants. The study started on 2020-08-01. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04612166?
The interventions under investigation include: Medication Action Plan and Patient Empowerment (MAP-PE ) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04612166?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.